期刊文献+

脑梗死患者纤维蛋白原浓度及MPV的动态变化 被引量:1

Dynamic changes of the concentration of fibrinogen and mean platelet volume in patient with cerebral infarction
下载PDF
导出
摘要 大量资料表明凝血和纤溶是血栓疾病的主要病理生理过程,脑梗死患者存在着凝血和纤溶过程的异常。纤维蛋白原(Fg)作为心脑血管疾病的独立危险因子,其在急性脑梗死发作时与血小板平均体积(Mean Platelet Volume,MPV)的关系国内尚未见报道。为此,本文利用测定脑梗死患者的上述指标及分析相关临床资料,发现它们与疾病发展进程之间的联系,以便对脑梗死发作的早期预防及临床治疗提供依据。
出处 《武警医学院学报》 CAS 2006年第5期478-479,共2页 Acta Academiae Medicinae CPAPF
  • 相关文献

参考文献5

  • 1OnoN, Koyama T, Suehiro A, et al. Clinical significance of new coagulation and fibrinolytic markers in ischemic stroke patients[J]. Stroke, 1991, 22: 1369-1373.
  • 2中华医学会全国第四次脑血管病学术会议.各类脑血管病诊断要点[J].中华神经科杂志,1996,29(5):379-379.
  • 3吕波,赵斌,邢永前,许志恩,李君良,陈小江.脑梗死患者纤维蛋白原β-148C/T基因多态性的研究[J].临床神经病学杂志,2003,16(4):202-204. 被引量:13
  • 4Cardemann A, Schwartz O, Haberbosch W. Positive association of the beta fibrinogen HI/H2 gene variation tobasal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction[J]. Thromb Haemost, 1997, 77: 1120.
  • 5Kfistensen SD. Megakaryocytes and atherosclerosis [J]. Clin Sci, 1992, 82: 353.

二级参考文献8

  • 1Mazoyer E, Sofia S. Risk factors and outcomes for atherothomhotic disease in French patients: the RIVAGE study. Thomb Res, 1999, 15 : 163.
  • 2Fuller GM ,Zhang Z.Transcriptional control mechanism of fibfinogen gene ezpression. Ann N Y Acad Sci,2001,936:469.
  • 3Lahiri DK, Schuabel B. DNA isolation by a rapid method from human blood samples: Effect of MgCl2, EDTA, storage time, and temperature on DNA yield and quality . Biochem Genet, 1993,32: 321.
  • 4Behague I,Poirier O, Nicaud V, et al.β-Fibrinogen gene polymorphisms are associated with plasma fibfinogen and coronary artery direase in patients with myocardial infarction .The ECTIM Study. Circulation, 1996,93:440.
  • 5Schmidt H, Schmidt R, Niederkom K, et al. Beta-fibrinogen gene pulymorphism(C-148 → T) is associated with carotid atherosclerosis:results of the Austrian Stroke Prevention Study. Arterioscler Thromb Vasc Biol, 1998,18:487.
  • 6Blake GJ, Schndtz C, Lindpaintner K, et al. Mutation in the promoter region of the beta-fibfinogen gene and the risk of future myocardial infarction,stroke and venous thrombosis. Eur Heart J, 2001,22:2262.
  • 7Cook DG, Cappuccio FP, Atkinson RW, et al. Ethnic differences in fibrinogen levels:the role of environmental factors and the beta-fibrinogen gene. Am J Epidemiol,2001,15:799.
  • 8Lacoviello L, Vischetti M, Zito F, et al. Genes encoding fibrinogen and cardicovascular risk. Hypertension, 2001,38 : 1199.

共引文献39

同被引文献37

  • 1曹勇军,钱进军,刘春风.纤维蛋白(原)、纤维蛋白(原)降解产物及其基序拮抗剂与动脉粥样硬化[J].国际脑血管病杂志,2006,14(4):290-293. 被引量:20
  • 2Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol, 2007, 27:15 -26.
  • 3Cavusoglu E, Ruwende C, Chopra V, et al. Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. Am Heart J, 2006, 151:1101. e1 -e8.
  • 4Verhoeven B, Hellings WE, Moll FL, et al. Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. J Vasc Surg, 2005, 42:1075 - 1081.
  • 5Jessup W, Kritharides L, Stocker R. Lipid oxidation in atherogenesis: an overview. Biochem Soc Trans, 2004, 32:134 - 138.
  • 6Uno M, Kitazato KT, Nishi K,et al. Raised plasma oxidised LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry, 2003, 74: 312 -316.
  • 7Uno M,Harada M, Takimoto O, et al. Elevation of plasma oxidized LDL in acute stroke patients is associated with ischemic lesions depicted by DWI and predictive of infarct enlargement. Neurol Res, 2005, 27:94 - 102.
  • 8Egashira K. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.Hypertension, 2003,41 : 834 - 841.
  • 9Namiki M, Kawashima S, Yamashita T, et al. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler Thromb Vasc Biol, 2002, 22: 115 - 120.
  • 10Inoue S, Egashira K, Ni W, et al. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation, 2002, 106: 2700 - 2706.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部